查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1209786

全球移植市場：到 2028 年的預測——按產品、應用、最終用戶和地區分析

Transplantation Market Forecasts to 2028 - Global Analysis By Product, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3個工作天內

價格

全球移植市場在 2022 年將達到 138 億美元，預計到 2028 年將達到 264 億美元，在預測期內以 11.4% 的複合年增長率增長，據 Stratistics MRC 我預計.

移植是將器官或組織從一個身體移植到另一個身體的外科手術。 移植通常在發生器官衰竭時進行。 器官衰竭通常由多種因素引起，包括嚴重創傷、失血、中毒、藥物濫用、白血病、敗血症和其他急性疾病。 在心臟、腎臟、肝臟、肺、胰腺、腸、胸腺和子宮等器官上進行移植。 腎功能衰竭和狼瘡等慢性病的增加需要緊急器官更換，導致移植增加。

器官採購和移植網絡（OPTN）的初步數據顯示，美國已經進行了42,000例器官移植，增長了5.9%，等待器官移植的患者有1,22915人。。

市場動態

驅動程序

對 3D 生物打印的需求不斷增長

器官捐獻者的持續短缺和等待器官移植的患者數量不斷增加增加了對 3D 生物打印的需求。 這些技術用於創建定制的假體、製造組織並支持合成模型的植入。 3D 生物打印技術的引入增加了全球器官移植手術的數量，導致移植市場的增長。

抑製劑

器官移植費用高

器官移植是一個積累高額費用的大過程，因為所有移植的器官都必須經過一系列的評估、匹配、篩選和等待程序，然後才能用於移植手術。 此外，通常很難獲得器官和進行移植手術。 它還包括患者的住院費用，因為他們將在移植前住院。 最困難的部分是獲得廉價的器官捐獻者。 這阻礙了市場的增長。

機會

移植技術的進步

隨著移植技術的進步和製造商新產品的推出，腎臟、肝臟、心臟、肺和組織移植的數量正在增加。 這導致移植中心和醫療保健中心的數量增加。 改進的醫療基礎設施、專業外科醫生的可用性以及具有卓越技術的先進產品正在推動市場的增長。

威脅

漫長的等待時間

由於器官稀缺，器官移植等待時間很長。 越來越需要這樣的程序來有效地照顧危重病人。 器官捐贈者必須準備好捐贈器官，但器官必須滿足所有要求並準備好移植。 找到完美的捐贈者可能需要數月甚至數年的時間。 結果，它有時會導致患者死亡，從而阻礙了市場的增長。

COVID-19 的影響

Covid 大流行並沒有擾亂醫療保健行業，但它導致全球器官移植登記量下降。 移植和器官捐獻手術數量的下降主要是由於資源、值班外科醫生、封鎖和旅行限制等不可用因素造成的。 由於可能感染，報告 COVID-19 呈陽性的患者避免了器官捐獻。 COVID-19 療法和免疫抑製劑之間的相互作用已導致移植物捐獻者出現大量器官衰竭，這引起了人們的極大關注。

預計在預測期內紙巾產品部分將是最大的部分

由於新產品的開發，衛生紙產品部門預計將實現有利增長。 用於組織器官移植的主要產品是組織製品、免疫抑製劑和保存液。 用於組織癒合、恢復正常功能和減輕疼痛的骨科手術有所增加。 人工耳蝸、心臟瓣膜、骨髓、骨科軟組織等植入手術數量的增加以及世界人口老齡化正在促進這一細分市場的增長。

預計免疫抑製劑部分在預測期內的複合年增長率最高。

免疫抑製劑部分預計在預測期內將呈現最快的複合年增長率增長，因為它具有降低人體排斥移植器官能力等優勢。 由於自身免疫性疾病如斑禿、多發性硬化症、關節炎和腎、肺、肝和心臟等器官衰竭的發病率不斷增加，這些藥物被大量使用。

市場份額最高的地區

由於用於治療的創新植入式產品的持續開發，預計北美在預測期內將佔據最大的市場份額。 該地區擁有發達的醫療系統。 該地區的人們顯著增加了個人健康支出。 各種大型生物技術和醫療設備公司的存在，以及政府的支持政策，預計將提振該地區的收益。

複合年增長率最高的地區

由於慢性病和交通事故的增加，預計亞太地區在預測期內的複合年增長率最高。 各種慢性病的高患病率和交通事故的增加對器官造成永久性損傷，需要用健康器官替換受損器官以挽救患者的生命。 該地區主要參與者在移植技術方面的持續進步表明市場正在穩步增長。

主要發展

2022 年 3 月，Zimmer Biomet 與 Biocomposites 簽訂了一項多年期協議，在美國獨家商業化具有新混合系統和交付選項的 Genex 骨移植替代品。

2022 年 1 月，諾華開始與 Alnylam 聯合研究用於恢復肝功能的靶向治療藥物。 Alnylam 的 Sirna 技術旨在促進功能性肝細胞再生，是肝功能衰竭患者的替代療法。

本報告的內容

  • 按地區和國家細分的市場細分
  • 向新進入者提出戰略建議
  • 2020、2021、2022、2025 和 2028 年的綜合市場數據
  • 市場趨勢（驅動因素、制約因素、機會、威脅、挑戰、投資機會、建議）
  • 根據市場預測在關鍵業務領域提出戰略建議
  • 競爭格局映射主要共同趨勢
  • 公司簡介，包括詳細的戰略、財務狀況和近期發展
  • 映射最新技術進步的供應鏈趨勢

免費定制服務

訂閱此報告的客戶將免費獲得以下自定義選項之一。

  • 公司簡介
    • 其他市場參與者的綜合概況（最多 3 家公司）
    • 主要參與者的 SWOT 分析（最多 3 家公司）
  • 區域細分
    • 根據客戶要求對主要國家/地區的市場進行估算、預測和復合年增長率（注意：基於可行性檢查。）
  • 競爭基準
    • 根據產品組合、地域分佈和戰略聯盟對主要參與者進行基準測試

內容

第 1 章執行摘要

第2章前言

  • 概覽
  • 利益相關者
  • 調查範圍
  • 調查方法
    • 數據挖掘
    • 數據分析
    • 數據驗證
    • 研究方法
  • 調查來源
    • 主要研究信息來源
    • 二手研究資源
    • 假設

第3章市場趨勢分析

  • 司機
  • 約束因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第 5 章全球移植市場：按產品分類

  • 保存解決方案
  • 紙巾產品
  • 免疫抑製劑
  • 其他產品

第 6 章全球移植市場：按應用

  • 組織移植
  • 器官移植
  • 其他應用

第 7 章。全球移植市場：按最終用戶分類

  • 移植中心
  • 醫院
  • 其他最終用戶

第 8 章全球移植市場：區域

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 意大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 新西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中東和非洲
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 卡塔爾
    • 南非
    • 其他中東地區

第9章主要進展

  • 合同、夥伴關係、協作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章公司簡介

  • Novartis AG
  • 21 st Century Medicine
  • Stryker Corporation
  • TransMedics
  • Zimmer Biomet
  • Astellas Pharma Inc
  • Medtronic
  • AbbVie Inc
  • Biolife Solutions
  • Teva Pharmaceutical
  • Veloxis Pharmaceuticals Inc
  • Abbott
  • Becton, Dickinson and Company（BD）
  • BioMerieux SA
  • Bio-Rad Laboratories Inc
  • CareDx Inc
  • F. Hoffmann-La Roche Ltd
  • Hologic Inc
  • Illumina Inc
  • QIAGEN
  • Arthrex Inc
Product Code: SMRC22208

According to Stratistics MRC, the Global Transplantation Market is accounted for $13.8 billion in 2022 and is expected to reach $26.4 billion by 2028 growing at a CAGR of 11.4% during the forecast period. Transplantation is a surgical procedure of implanting an organ or tissue from one body to another body. It is usually done when there is an organ failure. Organ failure generally occurs due to various factors such as serious trauma, loss of blood, poisoning, drug abuse, leukaemia, sepsis and other acute diseases. Transplantation was done to organs like heart, kidneys, liver, lungs, pancreas, intestine, thymus and uterus. Increase in chronic diseases such as kidney failure and lupus needs immediate change of organs which led to rise in transplantation.

According to the preliminary data from the Organ Procurement and Transplantation Network (OPTN), 42,000 organ transplants were performed in U.S with an increase of 5.9% and 1,22,915 patients are waiting to receive organs for transplant.

Market Dynamics:

Driver:

Increasing demand of 3D bioprinting

The continuous shortage of organ donors and the increasing number of patients on the waiting list for organ transplants have increased the demand for 3D bioprinting. These techniques are used to create customized prosthetics, fabricate tissue, and to support transplantation through synthetic models. The introduction of 3D bioprinting techniques has led to the growth of the transplantation market by driving the number of organ transplant procedures globally.

Restraint:

High cost for transplantation

Organ transplantation accumulates high cost due to its large process because every transplant organ must go through a series of evaluation, matching, screening and waiting procedures before it can be used in the transplant surgery. It is often difficult for patients to secure organs and transplant surgeries. The costs include the patient's hospitalization as they stay before transplant also. Acquisition of organ donor for lesser prices is the most difficult aspect. This reason hampers the market growth.

Opportunity:

Advancement in transplantation technology

Advancement in transplantation technology and the launch of new products by manufacturers has raised the number of transplant procedures including kidney, liver, heart, lungs and tissues. This increased the number of transplant centers and healthcare centers. Well-developed healthcare infrastructure and availability of expert surgeons & advanced products with better technology has propelled the growth of the market.

Threat:

Extensive wait time

Organ transplantation takes extensive wait time due to the fewer organ donations. There is an increased need for these procedures to care for the critically patient population effectively. Even the donor is ready to donate the organ; the organ should match all the requisites and should be fully fledgeble to be transplanted. To get a perfect donor, it will almost take few months and can also be extended for too many years. This can sometimes even cause death of the patient and thus it hinders the growth of the market.

COVID-19 Impact

The covid pandemic did not hit the healthcare industry into disarray but caused a drop in organ transplant surgery enrolment worldwide. The decrease in the number of transplantation and organ donation procedures is mainly because of factors such as unavailability of resources, engaged surgeons, lockdown and travel restrictions. Patients with positive reports for COVID-19 were refrained from donating organs due to the possibility of infection. The immunosuppressant drug interactions with COVID-19 therapy agents, had led to a significant number of organ failures from graft donors which became the major concern.

The tissue products segment is expected to be the largest during the forecast period

The tissue products segment is estimated to have a lucrative growth, due to its new product development. Major products used for tissue or organ transplantation are tissue products, immune suppressants and preservation solutions. It has raised the orthopedic procedures for tissue healing, normal functioning restoration and pain minimization. The increasing number of transplantation procedures such as that of cochlear, heart valves, bone marrow and orthopedic soft tissues and the rising geriatric population across the globe is attributed to the growth of the segment.

The immunosuppressive drugs segment is expected to have the highest CAGR during the forecast period

The immunosuppressive drugs segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the benefits this drug offers such as lowering the body ability to reject a transplanted organ. These drugs are highly used for auto immune disorders, such as alopecia areata, multiple sclerosis and arthritis, combined with the rising incidence of organ failures, especially the kidneys, lungs, liver, and heart.

Region with highest share:

North America is projected to hold the largest market share during the forecast period owing to their continuous development of innovative transplantation products for treatment. This region has well-developed healthcare system. The population here are increasing expenditure on personal health drastically. Strong presence of various large-scale biotechnology and medical device companies and presence of supportive government policies is expected to drive revenue growth of this region.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to the increase in chronic diseases and road accidents. High prevalence of various chronic diseases and increasing incidence of road accidents are causing permanent damage to the organs resulting in replacement of damaged organs with healthy organs in order to save patient's life. Continuous advancements in transplantation technology by major players in this region are registering the steady growth in the market.

Key players in the market

Some of the key players profiled in the Transplantation Market include Novartis AG, 21st Century Medicine, Stryker Corporation, TransMedics, Zimmer Biomet, Astellas Pharma Inc, Medtronic, AbbVie Inc, Biolife Solutions, Teva Pharmaceutical, Veloxis Pharmaceuticals Inc, Abbott, Becton, Dickinson and Company (BD), BioMerieux SA, Bio-Rad Laboratories Inc, CareDx Inc, F. Hoffmann-La Roche Ltd, Hologic Inc, Illumina Inc, QIAGEN and Arthrex Inc.

Key Developments:

In March 2022, Zimmer Biomet entered into a multiyear agreement with Bio composites to exclusively distribute Genex Bone Graft Substitute with its new mixing system and delivery options in the U.S.

In January 2022, Novartis AG collaborated with Alnylam intending to explore targeted therapy to restore liver function. Alnylam's Sirna technology is intended to promote the regrowth of functional liver cells and is an alternative for liver failure patients.

Products Covered:

  • Preservation Solutions
  • Tissue Products
  • Immunosuppressive Drugs
  • Other Products

Applications Covered:

  • Tissue Transplant
  • Organ Transplant
  • Other Applications

End Users Covered:

  • Transplantation Centers
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Transplantation Market, By Product

  • 5.1 Introduction
  • 5.2 Preservation Solutions
  • 5.3 Tissue Products
  • 5.4 Immunosuppressive Drugs
  • 5.5 Other Products

6 Global Transplantation Market, By Application

  • 6.1 Introduction
  • 6.2 Tissue Transplant
  • 6.3 Organ Transplant
  • 6.4 Other Applications

7 Global Transplantation Market, By End User

  • 7.1 Introduction
  • 7.2 Transplantation Centers
  • 7.3 Hospitals
  • 7.4 Other End Users

8 Global Transplantation Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Novartis AG
  • 10.2 21 st Century Medicine
  • 10.3 Stryker Corporation
  • 10.4 TransMedics
  • 10.5 Zimmer Biomet
  • 10.6 Astellas Pharma Inc
  • 10.7 Medtronic
  • 10.8 AbbVie Inc
  • 10.9 Biolife Solutions
  • 10.10 Teva Pharmaceutical
  • 10.11 Veloxis Pharmaceuticals Inc
  • 10.12 Abbott
  • 10.13 Becton, Dickinson and Company (BD)
  • 10.14 BioMerieux SA
  • 10.15 Bio-Rad Laboratories Inc
  • 10.16 CareDx Inc
  • 10.17 F. Hoffmann-La Roche Ltd
  • 10.18 Hologic Inc
  • 10.19 Illumina Inc
  • 10.20 QIAGEN
  • 10.21 Arthrex Inc

List of Tables

  • Table 1 Global Transplantation Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Transplantation Market Outlook, By Product (2020-2028) ($MN)
  • Table 3 Global Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
  • Table 4 Global Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
  • Table 5 Global Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
  • Table 6 Global Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 7 Global Transplantation Market Outlook, By Application (2020-2028) ($MN)
  • Table 8 Global Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
  • Table 9 Global Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
  • Table 10 Global Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
  • Table 11 Global Transplantation Market Outlook, By End User (2020-2028) ($MN)
  • Table 12 Global Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
  • Table 13 Global Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 14 Global Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 15 North America Transplantation Market Outlook, By Country (2020-2028) ($MN)
  • Table 16 North America Transplantation Market Outlook, By Product (2020-2028) ($MN)
  • Table 17 North America Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
  • Table 18 North America Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
  • Table 19 North America Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
  • Table 20 North America Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 21 North America Transplantation Market Outlook, By Application (2020-2028) ($MN)
  • Table 22 North America Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
  • Table 23 North America Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
  • Table 24 North America Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
  • Table 25 North America Transplantation Market Outlook, By End User (2020-2028) ($MN)
  • Table 26 North America Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
  • Table 27 North America Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 28 North America Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 29 Europe Transplantation Market Outlook, By Country (2020-2028) ($MN)
  • Table 30 Europe Transplantation Market Outlook, By Product (2020-2028) ($MN)
  • Table 31 Europe Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
  • Table 32 Europe Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
  • Table 33 Europe Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
  • Table 34 Europe Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 35 Europe Transplantation Market Outlook, By Application (2020-2028) ($MN)
  • Table 36 Europe Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
  • Table 37 Europe Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
  • Table 38 Europe Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
  • Table 39 Europe Transplantation Market Outlook, By End User (2020-2028) ($MN)
  • Table 40 Europe Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
  • Table 41 Europe Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 42 Europe Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 43 Asia Pacific Transplantation Market Outlook, By Country (2020-2028) ($MN)
  • Table 44 Asia Pacific Transplantation Market Outlook, By Product (2020-2028) ($MN)
  • Table 45 Asia Pacific Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
  • Table 46 Asia Pacific Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
  • Table 47 Asia Pacific Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
  • Table 48 Asia Pacific Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 49 Asia Pacific Transplantation Market Outlook, By Application (2020-2028) ($MN)
  • Table 50 Asia Pacific Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
  • Table 51 Asia Pacific Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
  • Table 52 Asia Pacific Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
  • Table 53 Asia Pacific Transplantation Market Outlook, By End User (2020-2028) ($MN)
  • Table 54 Asia Pacific Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
  • Table 55 Asia Pacific Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 56 Asia Pacific Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 57 South America Transplantation Market Outlook, By Country (2020-2028) ($MN)
  • Table 58 South America Transplantation Market Outlook, By Product (2020-2028) ($MN)
  • Table 59 South America Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
  • Table 60 South America Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
  • Table 61 South America Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
  • Table 62 South America Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 63 South America Transplantation Market Outlook, By Application (2020-2028) ($MN)
  • Table 64 South America Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
  • Table 65 South America Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
  • Table 66 South America Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
  • Table 67 South America Transplantation Market Outlook, By End User (2020-2028) ($MN)
  • Table 68 South America Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
  • Table 69 South America Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 70 South America Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 71 Middle East & Africa Transplantation Market Outlook, By Country (2020-2028) ($MN)
  • Table 72 Middle East & Africa Transplantation Market Outlook, By Product (2020-2028) ($MN)
  • Table 73 Middle East & Africa Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
  • Table 74 Middle East & Africa Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
  • Table 75 Middle East & Africa Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
  • Table 76 Middle East & Africa Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 77 Middle East & Africa Transplantation Market Outlook, By Application (2020-2028) ($MN)
  • Table 78 Middle East & Africa Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
  • Table 79 Middle East & Africa Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
  • Table 80 Middle East & Africa Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
  • Table 81 Middle East & Africa Transplantation Market Outlook, By End User (2020-2028) ($MN)
  • Table 82 Middle East & Africa Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
  • Table 83 Middle East & Africa Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 84 Middle East & Africa Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)